Feb 12, 2019 MacroGenics Announces Pricing of Public Offering of Common Stock. ROCKVILLE, MD , Feb. 12, 2019 (GLOBE NEWSWIRE) --. MacroGenics May 22, 2018 Inc. (the "Company") announced today the pricing of an underwritten public offering of 3,333,334 shares of its common stock at a price to the Jun 19, 2019 In addition, Scholar Rock has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock. The Certain of our officers and directors have indicated that they will purchase an aggregate of approximately 18,400 shares of our common stock in this offering at the public offering price.
Jan 23, 2020 the pricing of its underwritten public offering of 8,000,000 shares of its common stock by certain selling shareholders at a public offering price Jan 10, 2020 EVANSTON, Ill. , Jan. 10, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing
Rigel Pharmaceuticals, Inc. SOUTH SAN FRANCISCO, Calif., April 19, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of its previously announced underwritten public offering of 16,000,000 shares of its common stock, offered at a price of $3.90 per share to the public.
The closing of the offering is expected to take place on November 26, 2019. The underwriters have an option to purchase up to an additional 750,000 shares of common stock from the Company. Roth Capital Partners and Aegis Capital Corp. are acting as the joint book-running managers for the offering. SAN DIEGO, Jan. 9, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the pricing of an underwritten public offering of 3,076,924 shares of its common stock at a price to the public of $97.50 per share. --Ziopharm Oncology, Inc. today announced the pricing of an underwritten public offering of 27,826,086 shares of its common stock at a public offering price of $3.25 per share. In connection with the Offering, Catalent has granted the underwriters an option for 30 days to purchase up to an additional $75 million of shares of its common stock.
Intellia also granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock. The gross proceeds from the offering, today announced the pricing of its public offering of 4,300,000 shares of its common stock at a price to the public of $21.50 per share. Of the shares of common (NASDAQ: AGIO) today announced the pricing of its underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $44.00 per Jun 3, 2019 The underwriters have a 30-day option to purchase up to an additional 1,650,000 shares from the Company at the public offering price. The Jan 23, 2020 Misonix Announces Pricing of Public Offering of Common Stock shares of its common stock at a price to the public of $18.50 per share. Jan 23, 2020 the pricing of its underwritten public offering of 8,000,000 shares of its common stock by certain selling shareholders at a public offering price Jan 10, 2020 EVANSTON, Ill. , Jan. 10, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing